Skip to content
healthcare.dev

oxymetazoline hcl

NDC 45802-410, oxymetazoline hydrochloride, spray, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-410
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
SPRAY
Route
NASAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-410 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYMETAZOLINE HYDROCHLORIDE.05 g/100mL

Pharmacologic classes

Imidazolines [CS]; Increased Sympathetic Activity [PE]; Vasoconstriction [PE]; Vasoconstrictor [EPC]

Package NDCNDC-11Package
45802-410-59458020410591 BOTTLE, SPRAY in 1 CARTON (45802-410-59) / 30 mL in 1 BOTTLE, SPRAY

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 45802041059

    GET /v1/drugs/nadac/45802041059

Use it

Look up 45802-410 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-410 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-410. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.